• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.简短报告：通过总IgG和竞争性Luminex免疫测定法检测HIV感染年轻女性对四价HPV疫苗的抗体反应
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):241-245. doi: 10.1097/QAI.0000000000001355.
2
Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.四价人乳头瘤病毒疫苗产生的长期抗人乳头瘤病毒6型（HPV6）、11型、16型和18型免疫反应的评估
Clin Vaccine Immunol. 2015 Aug;22(8):943-8. doi: 10.1128/CVI.00133-15. Epub 2015 Jun 17.
3
The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.通过总IgG和竞争性Luminex免疫测定法定义的四年内对加德西疫苗的体液免疫反应。
Hum Vaccin. 2011 Feb;7(2):230-8. doi: 10.4161/hv.7.2.13948. Epub 2011 Feb 1.
4
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial.在四价 HPV 疫苗试验中，使用假病毒中和、Merck cLIA 和 Merck 总 IgG LIA 免疫分析检测 HPV 16 和 HPV 18 抗体反应，降低剂量。
Vaccine. 2014 Jan 23;32(5):624-30. doi: 10.1016/j.vaccine.2013.09.007. Epub 2013 Sep 19.
5
Evaluation on the persistence of anti-HPV immune responses to the quadrivalent HPV vaccine in Chinese females and males: Up to 3.5 years of follow-up.评价四价 HPV 疫苗在中国女性和男性中针对 HPV 免疫应答的持久性：长达 3.5 年的随访。
Vaccine. 2018 Mar 7;36(11):1368-1374. doi: 10.1016/j.vaccine.2018.02.006. Epub 2018 Feb 7.
6
Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.用于检测人乳头瘤病毒16型和18型的多重竞争性Luminex免疫测定、多重IgG Luminex免疫测定和基于假病毒的中和测定之间的一致性评估。
Vaccine. 2014 Oct 7;32(44):5880-7. doi: 10.1016/j.vaccine.2014.08.004. Epub 2014 Aug 19.
7
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.在感染HIV的儿童中四价人乳头瘤病毒疫苗接种后特定类型免疫的四年持续性：第四剂疫苗的效果
Vaccine. 2017 Mar 23;35(13):1712-1720. doi: 10.1016/j.vaccine.2017.02.021. Epub 2017 Feb 24.
8
Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.用于9种人乳头瘤病毒类型的人乳头瘤病毒竞争性鲁米诺免疫测定法的开发。
Hum Vaccin Immunother. 2014;10(8):2168-74. doi: 10.4161/hv.29205.
9
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1.肛门生殖器人乳头瘤病毒DNA与HIV-1感染女性对四价HPV疫苗的持续应答
Papillomavirus Res. 2018 Dec;6:15-21. doi: 10.1016/j.pvr.2018.08.002. Epub 2018 Aug 16.
10
Immunogenicity and safety of quadrivalent human papillomavirus types 6/11/16/18 recombinant vaccine in chronic kidney disease stage IV, V and VD.四价人乳头瘤病毒6/11/16/18型重组疫苗在慢性肾脏病IV期、V期和透析期的免疫原性及安全性
Nephrol Dial Transplant. 2017 Jan 1;32(1):132-136. doi: 10.1093/ndt/gfv444.

引用本文的文献

1
Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis.人免疫缺陷病毒感染者中HPV疫苗的免疫原性、安全性和有效性：一项系统评价与荟萃分析
EClinicalMedicine. 2022 Aug 3;52:101585. doi: 10.1016/j.eclinm.2022.101585. eCollection 2022 Oct.
2
Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.人乳头瘤病毒抗体水平和四价疫苗在围产期人类免疫缺陷病毒感染和暴露、未感染青少年中的临床效果。
Clin Infect Dis. 2019 Sep 13;69(7):1183-1191. doi: 10.1093/cid/ciy1040.
3
A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men.一剂延迟接种的四价人乳头瘤病毒疫苗在HIV-1感染男性中显示出免疫记忆。
Papillomavirus Res. 2018 Dec;6:11-14. doi: 10.1016/j.pvr.2018.05.001. Epub 2018 May 26.
4
Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.HIV 感染儿童对四价 HPV 疫苗的记忆 B 细胞和 T 细胞应答的持久性。
AIDS. 2018 Apr 24;32(7):851-860. doi: 10.1097/QAD.0000000000001773.

本文引用的文献

1
Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.四价人乳头瘤病毒疫苗产生的长期抗人乳头瘤病毒6型（HPV6）、11型、16型和18型免疫反应的评估
Clin Vaccine Immunol. 2015 Aug;22(8):943-8. doi: 10.1128/CVI.00133-15. Epub 2015 Jun 17.
2
Long-term efficacy and safety of human papillomavirus vaccination.人乳头瘤病毒疫苗接种的长期疗效和安全性。
Int J Womens Health. 2014 Dec 3;6:999-1010. doi: 10.2147/IJWH.S50365. eCollection 2014.
3
Vaccination against oncogenic human papillomavirus infection in HIV-infected populations: review of current status and future perspectives.HIV感染人群中针对致癌性人乳头瘤病毒感染的疫苗接种：现状与未来展望综述
Sex Health. 2014 Dec;11(6):511-23. doi: 10.1071/SH14015.
4
Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults.四价人乳头瘤病毒疫苗在 HIV 感染和 HIV 阴性青少年和年轻成人中的安全性和免疫原性。
Vaccine. 2014 Sep 29;32(43):5657-61. doi: 10.1016/j.vaccine.2014.08.011. Epub 2014 Aug 20.
5
Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18.用于检测人乳头瘤病毒16型和18型的多重竞争性Luminex免疫测定、多重IgG Luminex免疫测定和基于假病毒的中和测定之间的一致性评估。
Vaccine. 2014 Oct 7;32(44):5880-7. doi: 10.1016/j.vaccine.2014.08.004. Epub 2014 Aug 19.
6
Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.四价人乳头瘤病毒疫苗在HIV-1感染女性中的免疫原性和安全性
Clin Infect Dis. 2014 Jul 1;59(1):127-35. doi: 10.1093/cid/ciu238. Epub 2014 Apr 9.
7
Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil™ in adult women.Gardasil™ 在成年女性中的安全性、免疫原性和有效性的长期随访观察。
PLoS One. 2013 Dec 31;8(12):e83431. doi: 10.1371/journal.pone.0083431. eCollection 2013.
8
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.南非 HIV 阳性女性中 HPV-16/18 AS04 佐剂疫苗的安全性和免疫原性：一项部分盲随机安慰剂对照研究。
Vaccine. 2013 Nov 19;31(48):5745-53. doi: 10.1016/j.vaccine.2013.09.032. Epub 2013 Oct 1.
9
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.人类乳头瘤病毒 6、11、16、18 疫苗在感染 HIV 的年轻女性中的免疫原性和安全性。
Clin Infect Dis. 2013 Sep;57(5):735-44. doi: 10.1093/cid/cit319. Epub 2013 May 10.
10
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.HIV 感染女性的浸润性宫颈癌风险：一项北美多队列协作前瞻性研究。
J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):405-13. doi: 10.1097/QAI.0b013e31828177d7.

简短报告：通过总IgG和竞争性Luminex免疫测定法检测HIV感染年轻女性对四价HPV疫苗的抗体反应

Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.

作者信息

Kahn Jessica A, Xu Jiahong, Kapogiannis Bill G, Sleasman John W

机构信息

*Division of Adolescent and Transition Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH; †Westat, Rockville, MD; ‡Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD; and §Division of Allergy and Immunology and Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Duke University School of Medicine, Durham, NC.

出版信息

J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):241-245. doi: 10.1097/QAI.0000000000001355.

DOI:10.1097/QAI.0000000000001355
PMID:28291048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5429191/
Abstract

We compared antibody responses of HIV-infected young women to the human papillomavirus (HPV) 6, 11, 16, and 18 vaccine using total immunoglobulin (Ig) G Luminex immunoassay (LIA) and competitive Luminex immunoassay (cLIA) assays. HPV18 seropositivity after HPV vaccination as measured with IgG LIA remained high (98%) 48 weeks after vaccination, in contrast with seropositivity as measured with cLIA (73%). Seropositivity rates at week 48 as measured by both IgG LIA and cLIA remained high for HPV6, 11, and 16 (93.5%-100%). These results suggest that the lower rate of seropositivity to HPV18 when cLIA vs. IgG LIA is used is a function of the assay and does not imply lower vaccine immunogenicity.

摘要

我们使用总免疫球蛋白（Ig）G 液相芯片免疫分析（LIA）和竞争性液相芯片免疫分析（cLIA）检测，比较了感染人类免疫缺陷病毒（HIV）的年轻女性对人乳头瘤病毒（HPV）6、11、16和18型疫苗的抗体反应。接种疫苗后48周，用IgG LIA检测的HPV18血清阳性率仍保持在较高水平（98%），而用cLIA检测的血清阳性率为73%。用IgG LIA和cLIA检测的HPV6、11和16型在第48周时的血清阳性率也保持在较高水平（93.5%-100%）。这些结果表明，与IgG LIA相比，使用cLIA时HPV18血清阳性率较低是检测方法的作用，并不意味着疫苗免疫原性较低。